These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 34641958)

  • 41. Umbilical cord as a long-term source of activatable mesenchymal stromal cells for immunomodulation.
    Selich A; Zimmermann K; Tenspolde M; Dittrich-Breiholz O; von Kaisenberg C; Schambach A; Rothe M
    Stem Cell Res Ther; 2019 Sep; 10(1):285. PubMed ID: 31547865
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Conditioned Medium from Human Mesenchymal Stromal Cells: Towards the Clinical Translation.
    Sagaradze G; Grigorieva O; Nimiritsky P; Basalova N; Kalinina N; Akopyan Z; Efimenko A
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987106
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reproducibility of GMP-compliant production of therapeutic stressed peripheral blood mononuclear cell-derived secretomes, a novel class of biological medicinal products.
    Laggner M; Gugerell A; Bachmann C; Hofbauer H; Vorstandlechner V; Seibold M; Gouya Lechner G; Peterbauer A; Madlener S; Demyanets S; Sorgenfrey D; Ostler T; Erb M; Mildner M; Ankersmit HJ
    Stem Cell Res Ther; 2020 Jan; 11(1):9. PubMed ID: 31900195
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human amnion favours tissue repair by inducing the M1-to-M2 switch and enhancing M2 macrophage features.
    Magatti M; Vertua E; De Munari S; Caro M; Caruso M; Silini A; Delgado M; Parolini O
    J Tissue Eng Regen Med; 2017 Oct; 11(10):2895-2911. PubMed ID: 27396853
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of the impact of preservation methods on amniotic membrane properties for tissue engineering applications.
    Fenelon M; Maurel DB; Siadous R; Gremare A; Delmond S; Durand M; Brun S; Catros S; Gindraux F; L'Heureux N; Fricain JC
    Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109903. PubMed ID: 31500032
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome.
    Harrell CR; Fellabaum C; Jovicic N; Djonov V; Arsenijevic N; Volarevic V
    Cells; 2019 May; 8(5):. PubMed ID: 31100966
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The mesenchymal stem cell secretome: A new paradigm towards cell-free therapeutic mode in regenerative medicine.
    L PK; Kandoi S; Misra R; S V; K R; Verma RS
    Cytokine Growth Factor Rev; 2019 Apr; 46():1-9. PubMed ID: 30954374
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human Amniotic Membrane and Amniotic Membrane-Derived Cells: How Far Are We from Their Use in Regenerative and Reconstructive Urology?
    Ramuta TŽ; Kreft ME
    Cell Transplant; 2018 Jan; 27(1):77-92. PubMed ID: 29562770
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Amniotic fluid stem cell exosomes: Therapeutic perspective.
    Beretti F; Zavatti M; Casciaro F; Comitini G; Franchi F; Barbieri V; La Sala GB; Maraldi T
    Biofactors; 2018 Mar; 44(2):158-167. PubMed ID: 29341292
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Disclosing the molecular profile of the human amniotic mesenchymal stromal cell secretome by filter-aided sample preparation proteomic characterization.
    Muntiu A; Papait A; Vincenzoni F; Vitali A; Lattanzi W; Romele P; Cargnoni A; Silini A; Parolini O; Desiderio C
    Stem Cell Res Ther; 2023 Nov; 14(1):339. PubMed ID: 38012707
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Conditioned Medium from Human Amnion-Derived Mesenchymal Stem Cells Regulates Activation of Primary Hepatic Stellate Cells.
    Fu Q; Ohnishi S; Sakamoto N
    Stem Cells Int; 2018; 2018():4898152. PubMed ID: 30402110
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The mesenchymal stem cell secretome as an acellular regenerative therapy for liver disease.
    Driscoll J; Patel T
    J Gastroenterol; 2019 Sep; 54(9):763-773. PubMed ID: 31270691
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The secretome from human-derived mesenchymal stem cells augments the activity of antitumor plant extracts in vitro.
    Ramirez JA; Jiménez MC; Ospina V; Rivera BS; Fiorentino S; Barreto A; Restrepo LM
    Histochem Cell Biol; 2024 May; 161(5):409-421. PubMed ID: 38402366
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Potency Assays for Mesenchymal Stromal Cell Secretome-Based Products for Tissue Regeneration.
    Sagaradze G; Monakova A; Efimenko A
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298329
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Conditioned medium obtained from human amniotic mesenchymal stem cells attenuates focal cerebral ischemia/reperfusion injury in rats by targeting mTOR pathway.
    Nazarinia D; Aboutaleb N; Gholamzadeh R; Nasseri Maleki S; Mokhtari B; Nikougoftar M
    J Chem Neuroanat; 2019 Dec; 102():101707. PubMed ID: 31672459
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mapping of the Human Amniotic Membrane:
    Basile M; Centurione L; Passaretta F; Stati G; Soritau O; Susman S; Gindraux F; Silini A; Parolini O; Di Pietro R
    Cell Transplant; 2023; 32():9636897231166209. PubMed ID: 37077027
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Conditioned medium from horse amniotic membrane-derived multipotent progenitor cells: immunomodulatory activity in vitro and first clinical application in tendon and ligament injuries in vivo.
    Lange-Consiglio A; Rossi D; Tassan S; Perego R; Cremonesi F; Parolini O
    Stem Cells Dev; 2013 Nov; 22(22):3015-24. PubMed ID: 23795963
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of Trimetazidine and Diazoxide on immunomodulatory activity of human embryonic stem cell-derived mesenchymal stem cell secretome.
    Jahandideh S; Maghsood F; Ghahhari NM; Lotfinia M; Mohammadi M; Johari B; Kadivar M
    Tissue Cell; 2017 Oct; 49(5):597-602. PubMed ID: 28843336
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Therapeutic Properties of Mesenchymal Stromal/Stem Cells: The Need of Cell Priming for Cell-Free Therapies in Regenerative Medicine.
    Miceli V; Bulati M; Iannolo G; Zito G; Gallo A; Conaldi PG
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466583
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Conditioned Medium from Human Amnion-Derived Mesenchymal Stromal/Stem Cells Attenuating the Effects of Cold Ischemia-Reperfusion Injury in an In Vitro Model Using Human Alveolar Epithelial Cells.
    Miceli V; Bertani A; Chinnici CM; Bulati M; Pampalone M; Amico G; Carcione C; Schmelzer E; Gerlach JC; Conaldi PG
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33419219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.